Orrick is expanding its partnership with Harvey via an enterprise agreement to deploy the company's suite of GenAI solutions to all of the firm's lawyers and legal professionals.

The deployment is part of Orrick's broader plan to integrate GenAI safely and responsibly to improve the quality and efficiency of client advice and firm operations.

"Virtually every one of our clients feels the imperative to deliver greater value to the business through GenAI integration into their legal and compliance workflows," said Orrick Chair Mitch Zuklie. "Harvey has proven to be an important part of our toolkit as we partner with clients and innovate to meet this demand. We are looking forward to accelerating our impact in this area in 2026."

"Hundreds of Orrick lawyers have been integrating Harvey into workstreams for the past year and they've been a terrific partner in our training program. Many of our clients value the collaboration spaces Harvey offers," added Orrick Chief Innovation Officer Wendy Curtis. "Based on feedback from our clients and our team, we're excited to now make Harvey part of the suite of tools available to all Orrick professionals worldwide."

Harvey is part of a suite of GenAI solutions in use at the firm. In recognition of these efforts, Orrick is the only firm to earn a perfect score in the Digital category in the Financial Times Innovative Lawyers North America 2025 report for our successful integration of data, technology and GenAI.

Our GenAI toolkit combines proprietary technology and leading third-party solutions, including:

• Our in-house GenAI platform integrates Anthropic's Claude and other LLMs and recently surpassed one million prompts. Our team averages 3,100+ prompts daily.
• 35+ custom-built GenAI solutions developed in-house at Orrick Labs and Orrick Analytics.
• Draftwise, Hebbia and Orbital Witness, among our growing portfolio of legaltech solutions.

We pair our technology investment with innovation in staffing, training and professional development, including a first-year associate Residency with an emphasis on GenAI training, a Financial Times Innovation Award-winning Practice Analyst program that helps drive GenAI adoption and Innovation Attorneys embedded in each of our practice groups.

Through our LegalTech Initiative, we invest in emerging GenAI legal technologies - including Draftwise, Priori, Alta Claro and most recently Twin-1 AI - and partner with The Legal Tech Fund.